ReWalk Robotics Ltd. (RWLK)
$0.735
Rating:
Recommendation:
Buy
| Symbol | RWLK |
|---|---|
| Price | $0.735 |
| Beta | 2.478 |
| Volume Avg. | 0.22M |
| Market Cap | 45.669M |
| Shares () | - |
| 52 Week Range | 0.56-1.01 |
| 1y Target Est | - |
| DCF Unlevered | RWLK DCF -> | |
|---|---|---|
| DCF Levered | RWLK LDCF -> | |
| ROE | -29.65% | Sell |
| ROA | -29.99% | Sell |
| Operating Margin | - | |
| Debt / Equity | 1.96% | Neutral |
| P/E | -2.37 | Sell |
| P/B | 0.74 | Buy |
Latest RWLK news
About
Download (Excel)ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.